GC/MS/MS quantification of 11-dehydrothromboxane B2 in human urine
- 31 August 1992
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 46 (4) , 271-275
- https://doi.org/10.1016/0952-3278(92)90034-g
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of fish oil supplementation on the excretion of the major metabolite of prostaglandin E in healthy male subjectsLipids, 1991
- GC-MS Assay For 9α, 15(S)-Dihydroxy-11-Oxo-thromba-5(Z), 13(E)-Dien-1-oic AcidAnalytical Letters, 1989
- Analysis of the major urinary thromboxane metabolites, 2,3-dinorthromboxane b2 and 11-dehydrothromboxane b2, by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Methodology in prostaglandin and thromboxane assayProgress in Lipid Research, 1986
- The prostacyclin/thromboxane balance is favourably shifted in Greenland EskimosProstaglandins, 1986
- Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane productionProstaglandins, 1986
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976